Craig Muir

About Craig Muir

Craig Muir combines a broad background in science, engineering, and entrepreneurship to support the lab’s mission in ocean science and single-cell genomics. Craig studied Animal Physiology and Chemistry at UC Davis and shifted focus from a Ph.D. in muscle biophysics to biotechnology in the mid-80s. He pioneered lab automation in bioassays and protein engineering at UVM, Genentech, and Tularik.

At Millennium Pharmaceuticals, he led teams in genomics and proteomics, contributing to $2 billion in partnerships. In 2007, Craig joined Third Rock Ventures, helping establish their San Francisco office. Over 15 years, he was a founding investor in companies like Cytomx and Global Blood Therapeutics, driving innovations in drug discovery. Craig holds a degree in Animal Physiology and Chemistry from UC Davis, with extensive experience in biotech engineering and automation.

Craig has had a lifelong fascination with the intersection of science and nature, a passion he shares unconditionally with family and friends both new and old. For over 25 years, Craig has graciously shared his enthusiasm for exploring and appreciating freshwater and saltwater ecosystems on camping, swimming, fishing, or sailing excursions to the Haida Gwaii Islands off the coast of British Columbia, Trinity Lake in Northern California, and the waters of the Boothbay region. At Bigelow Laboratory, Craig applies his expertise to advance technological advancements and foster collaborations, supporting the lab’s mission to explore and understand ocean biology at the single-cell level.

Craig is active in both California and Maine, serving as an adjunct professor and advisor at UCSF and UC Davis. His interests include neuroscience, gene therapy, and machine learning. Craig aims to enhance Bigelow Laboratory’s capabilities in single-cell genomics and strengthen its impact through innovative research and partnerships.